| Factor Information | |
|---|---|
| Data ID | 426 |
| Factor | total health risk score |
| Description | Being religious/spiritual was a predictor for better health behaviors. |
| Biomarker | NA |
| Classification | D3 (molecular factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | to attain a better understanding of the relationship between religion/spirituality and health outcomes. |
| p Value | <0.05 |
| Conclusion | Multivariable GLMM, adjusting for patient characteristics and un- measured country differences, revealed that being religious/spiritual was a predictor for better health behaviors, better quality of life (LAS QOL), and a higher satisfaction with life (SWLS). Religiosity/spirituality is an independent predictor for some PROs, but has differential impact across countries. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 450 |
| CHD Type | non-isolated CHD |
| CHD Subtype | complex CHD |
| Reference | |
|---|---|
| PMID | 30077534 |
| Year | 2019 |
| Title | Religion and spirituality as predictors of patient-reported outcomes in adults with congenital heart disease around the globe. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | questionnaires | |
| Region | ArgentinaAustralia, Belgium, Canada, France, India, Italy, Japan, Malta, Norway, Sweden, Switzerland, Taiwan, the Netherlands, USA | |
| Method | APPROACH-IS was a cross-sectional study, in which 4028 patients from 15 countries were enrolled. Patients completed questionnaires to measure perceived health status; psychological functioning; health behaviors; and quality of life. | |
| Race | 15 countries from 5 continents | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | being religlous/spiritual CHD(Treatment) | none- religlous/spiritual CHD(Control) |
| Number | 1927 | 1992 |
| Age | 32 (IQR 25–43) years | 31 (IQR 25–40) years |
| Gender (Male: Female) | 803:1124 | 1058:934 |
| Marker Level | -1.4(0.6)(being religlous/spiritual CHD) | N/A(none- religlous/spiritual CHD) |
